NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,284 filers reported holding NOVARTIS A G in Q2 2024. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $112,315 | +10.1% | 1,055 | 0.0% | 0.08% | +6.8% |
| Q1 2024 | $102,050 | +0.1% | 1,055 | +5.4% | 0.07% | -20.7% |
| Q4 2023 | $101,962 | 0.0% | 1,001 | 0.0% | 0.09% | 0.0% |
| Q3 2023 | $101,962 | +0.9% | 1,001 | 0.0% | 0.09% | +1.1% |
| Q2 2023 | $101,011 | -62.3% | 1,001 | -69.4% | 0.09% | -32.1% |
| Q3 2021 | $268,000 | -19.8% | 3,275 | -10.6% | 0.13% | +3.9% |
| Q2 2021 | $334,000 | +4.0% | 3,665 | -2.5% | 0.13% | +6.6% |
| Q1 2021 | $321,000 | -32.7% | 3,759 | -25.7% | 0.12% | -31.6% |
| Q4 2020 | $477,000 | +14.1% | 5,056 | +5.1% | 0.18% | +7.9% |
| Q3 2020 | $418,000 | -9.9% | 4,811 | -9.5% | 0.16% | -15.5% |
| Q2 2020 | $464,000 | +0.4% | 5,317 | -5.1% | 0.19% | -21.1% |
| Q1 2020 | $462,000 | -2.9% | 5,605 | -0.1% | 0.25% | +8.4% |
| Q4 2019 | $476,000 | – | 5,610 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 318,637 | $27,960,000 | 7.08% |
| MANAGED ASSET PORTFOLIOS, LLC | 417,183 | $36,608,000 | 5.02% |
| SAL Trading, LLC | 233,600 | $20,498,000 | 4.77% |
| SCHARF INVESTMENTS, LLC | 1,340,680 | $117,662,000 | 3.49% |
| SAL Trading, LLC | 155,783 | $13,670,000 | 3.18% |
| First Fiduciary Investment Counsel, Inc. | 169,371 | $14,862,000 | 2.90% |
| PRENTISS SMITH & CO INC | 55,026 | $4,829,000 | 2.90% |
| GARLAND CAPITAL MANAGEMENT INC | 47,630 | $4,180,000 | 2.77% |
| Cullen Capital Management, LLC | 3,295,271 | $289,160,000 | 2.66% |
| WILKINS INVESTMENT COUNSEL INC | 133,880 | $11,748,000 | 2.65% |